Prostate Cancer Treatment in India for International Patients 2026
Priya Sharma
Oncology & Cancer Care Writer
Prostate Cancer Treatment in India for International Patients 2026
Prostate cancer is one of the most commonly diagnosed cancers in men globally, and across sub-Saharan Africa it is disproportionately diagnosed at later stages because routine PSA screening remains uncommon and diagnostic access is limited. For men in Nigeria, South Africa, Kenya, Ghana, and Tanzania who receive a prostate cancer diagnosis and need access to surgery, radiation, or advanced treatment options, India offers a realistic path: internationally trained specialists, the same da Vinci robotic surgical system used in the USA, modern radiation technology, and treatment costs that are 70–80% lower than Western prices.
This guide explains the treatment options for prostate cancer available in India, what they cost, which hospitals to consider, and how to plan a trip for diagnosis, treatment, or a second opinion.
TL;DR: Robotic radical prostatectomy in India costs $6,500–9,000. Radiation therapy (IMRT/VMAT) costs $5,000–8,000 for a full course. HIFU costs $8,000–12,000. All options are available at JCI-accredited hospitals using the same equipment as top US and UK cancer centres. Indian oncology teams offer remote second opinions within 48–72 hours on receipt of your biopsy and MRI reports.
Understanding Prostate Cancer: Staging and Treatment Decision
Prostate cancer treatment decisions depend primarily on the stage and grade of the cancer (Gleason score / Grade Group) and the patient's overall health and preferences. The major staging categories are:
Localised prostate cancer (confined to the prostate):
Stage I–II / PSA < 20 ng/mL / Gleason ≤ 7 (Grade Group 1–2)
Options: Active surveillance, robotic surgery, radiation therapy (IMRT/VMAT/SBRT), HIFU, or brachytherapy
Locally advanced prostate cancer (extending beyond the prostate):
Stage III / PSA > 20 ng/mL / Gleason 8–10 (Grade Group 4–5)
Options: Surgery with extended lymph node dissection, radiation + long-term hormone therapy (ADT)
Metastatic prostate cancer:
Stage IV / spread to lymph nodes, bone, or distant sites
Options: Hormone therapy (ADT), docetaxel or cabazitaxel chemotherapy, enzalutamide, abiraterone, radium-223 for bone metastases, PSMA-targeted therapy
Indian hospitals handle all of these stages — including complex locally advanced and metastatic cases — with oncology teams working as multi-disciplinary tumour boards in the same way as major Western cancer centres.
Treatment Options and Costs in India
1. Robotic Radical Prostatectomy (da Vinci Surgery)
Robotic prostatectomy using the da Vinci Surgical System is the gold-standard surgical treatment for localised and selected locally advanced prostate cancer. India has one of the highest concentrations of da Vinci robotic systems in Asia — over 80 systems across major centres.
What it involves: The prostate gland is removed via 4–5 small keyhole incisions. The robotic system provides the surgeon with magnified 3D vision and articulated instrument movement beyond what the human hand can replicate unaided. The result is less blood loss, less post-operative pain, shorter hospital stay, and comparable or better preservation of urinary continence and sexual function compared to open surgery.
Outcomes at Indian centres:
- Positive surgical margin rate (cancer cells at the edge): 15–25% for pT2 disease, equivalent to leading Western centres
- Urinary continence at 12 months (continent without pads): 85–95%
- Potency preservation at 12 months (with nerve-sparing technique): 65–80% in appropriate candidates
Cost in India:
| Hospital | Robotic Prostatectomy Cost |
|---|---|
| Apollo Hospitals Delhi | $7,000–9,000 |
| Fortis Healthcare Delhi | $7,000–8,500 |
| Medanta — The Medicity | $7,500–9,000 |
| Max Healthcare Delhi | $6,500–8,500 |
| Kokilaben Hospital Mumbai | $7,000–9,000 |
| Manipal Hospitals Bangalore | $6,500–8,000 |
Comparison: Robotic prostatectomy in the USA costs $35,000–55,000. In the UK's private sector: $25,000–40,000.
Hospital stay: 2–3 days. Catheter in place for 7–10 days after discharge. International patients typically stay in India for 2–3 weeks total.
2. External Beam Radiation Therapy (IMRT / VMAT / SBRT)
Radiation therapy is a non-surgical option for localised and locally advanced prostate cancer that delivers equivalent cancer control to surgery in most clinical scenarios.
IMRT (Intensity Modulated Radiation Therapy): Shapes the radiation beam to conform tightly to the prostate while minimising dose to the bladder and rectum. Standard course: 25–37 daily fractions over 5–7 weeks.
VMAT (Volumetric Arc Therapy): A faster delivery form of IMRT. Same clinical outcome, shorter daily treatment time (typically 2–4 minutes per session vs 8–15 for conventional IMRT).
SBRT / SABR (Stereotactic Body Radiation): High-dose, hypofractionated treatment delivered in 5 fractions over 1–2 weeks. Equivalent outcomes to conventional IMRT for localised cancer with significantly shorter treatment course — increasingly preferred for African patients who want to minimise time in India.
Brachytherapy: Radioactive seeds implanted directly into the prostate. Available at select centres. Used for low-risk localised disease.
Cost in India:
| Treatment | Cost in India |
|---|---|
| IMRT / VMAT (full course) | $5,000–8,000 |
| SBRT (5 fractions) | $4,500–7,000 |
| Brachytherapy | $6,000–9,000 |
| Radiation + hormone therapy (combined) | $7,000–11,000 |
Comparison: A full radiation course in the USA costs $40,000–80,000. In the UK private sector: $20,000–35,000.
Indian centres with radiation oncology: Apollo Cancer Centres, HCG Oncology (multiple cities), Tata Memorial Hospital Mumbai, AIIMS Delhi, Fortis Cancer Institute.
3. HIFU (High-Intensity Focused Ultrasound)
HIFU uses focused ultrasound energy to generate heat that precisely ablates prostate tissue — effectively destroying cancer cells without incisions, without radiation, and without general anaesthesia (spinal anaesthesia is typically used). It is a same-day procedure.
HIFU is FDA-approved and widely accepted for localised low-to-intermediate risk prostate cancer. It offers a genuine alternative to surgery or radiation for well-selected patients who prefer a minimally invasive, single-treatment approach.
Focal HIFU vs whole-gland HIFU:
- Whole-gland HIFU: treats the entire prostate — equivalent intent to surgery or radiation
- Focal HIFU: treats only the tumour-bearing zone — preserves more healthy tissue, lower side effect profile
Cost in India:
- Whole-gland HIFU: $9,000–12,000
- Focal HIFU: $10,000–13,000
Comparison: HIFU in the UK costs $25,000–40,000. Available in limited centres in the USA at $30,000–50,000.
Indian centres offering HIFU: Apollo Hospitals Delhi, Fortis Healthcare, Manipal Hospitals Bangalore.
4. Hormone Therapy (Androgen Deprivation Therapy)
ADT (hormone therapy) reduces testosterone levels that fuel prostate cancer growth. Used:
- As primary treatment for metastatic disease
- Combined with radiation for locally advanced disease
- As neoadjuvant therapy before surgery in select cases
- As palliative management
ADT medications (LHRH agonists like leuprolide, LHRH antagonists like degarelix, and anti-androgens) are far cheaper in India than in Western markets.
| Medication | India Monthly Cost | USA Monthly Cost |
|---|---|---|
| Leuprolide (Lupron) 3-month depot | $120–180 | $1,200–2,000 |
| Enzalutamide (Xtandi) | $800–1,500 | $6,000–9,000 |
| Abiraterone (Zytiga) | $200–400 | $5,000–8,000 |
| Docetaxel (chemotherapy) per cycle | $150–250 | $1,500–3,000 |
For patients on long-term hormonal therapy, the medication cost savings alone can justify a trip to India to establish a treatment plan and purchase a supply.
Which Indian Hospitals Lead in Prostate Cancer Treatment?
Apollo Cancer Centres (Delhi, Chennai, Hyderabad, Mumbai)
Apollo has built dedicated cancer centres at its flagship locations with multi-disciplinary tumour boards, robotic surgery, advanced radiation platforms (including SBRT and CyberKnife), and a track record with international patients. The Uro-Oncology department at Apollo Delhi handles over 500 prostate cancer cases annually.
HCG Oncology (Bangalore, Ahmedabad, multiple cities)
HCG is India's largest oncology specialist network — over 25 comprehensive cancer centres across India. HCG's strength is its focus: it does only cancer, across every treatment modality. For patients whose only need is oncology rather than multi-specialty care, HCG is highly recommended.
Tata Memorial Hospital (Mumbai)
India's national cancer institute — a government-run centre that combines world-class clinical research with affordable care. Tata Memorial is globally respected and handles the highest volume of complex cancer cases in India. For complex or metastatic prostate cancer, Tata Memorial's oncology teams offer expertise that rivals any specialist cancer centre in the world.
Note: Tata Memorial is a government institution and is significantly more affordable than private hospitals — some treatments cost 50–70% less than Apollo or Fortis — but waiting times and the paperwork process are longer. For international patients, private hospitals are typically recommended for speed and coordination ease.
Medanta — The Medicity (Gurgaon)
Medanta's Cancer Institute handles all modalities including robotic prostatectomy, HIFU, IMRT, and advanced systemic therapies. The international patient department is experienced with African patients and can arrange rapid pre-travel second opinions.
Fortis Healthcare (multiple cities)
Fortis's oncology program spans surgery, medical oncology, and radiation across its major hospitals. Fortis Gurugram has a strong uro-oncology team with high robotic surgery volume.
Getting a Second Opinion from India Before You Travel
Many international patients start with a remote second opinion before committing to travel. This is free through Arodya and takes 48–72 hours once records are submitted.
What to send:
- Biopsy report (including Gleason score, number of cores positive, and tumour percentage per core)
- PSA history (ideally 3–5 values over time, not just the most recent)
- MRI of the prostate (mpMRI — multiparametric MRI is the gold standard; if you have a PI-RADS score, include it)
- Bone scan or PSMA-PET scan if ordered (for staging)
- CT or PET scan if locally advanced or metastatic disease is suspected
- Current medications and comorbidities
Indian uro-oncologists will review this and provide a formal second opinion — treatment recommendation, suitability for robotic surgery or alternative modalities, and an initial cost estimate — before you book flights.
For complex cases, Arodya can arrange opinions from multiple specialists simultaneously so you can compare recommendations. This is exactly what patients with serious diagnoses need before making a high-stakes decision.
What to Expect During Your Treatment Trip
For robotic surgery patients:
Total India stay: 2–3 weeks
- Day 1: Pre-operative assessment — full blood work, cardiac evaluation, anaesthesia consultation
- Day 2: Robotic prostatectomy (2.5–4 hours); recovery in hospital
- Days 3–4: Hospital; catheter in place; walking on Day 1 post-op
- Days 5–7: Discharge with catheter still in place
- Week 2: Follow-up; catheter removal (typically Day 7–10)
- Week 3: Final pre-departure review; post-operative PSA scheduled for 6 weeks post-surgery
- Post-return: Arodya coordinates remote PSA follow-up consultations with your Indian oncology team
For radiation therapy patients:
SBRT patients: 2–3 weeks total (5 treatment sessions spread over 1–2 weeks)
Conventional IMRT/VMAT patients: 6–8 weeks total
Many IMRT patients combine their treatment trip with an extended stay, using Delhi or Chennai as their base for the duration of the radiation course.
Travelling to India for Prostate Cancer Treatment: Logistics
Medical visa: Apply at indianvisaonline.gov.in. Required: valid passport, passport photo, hospital appointment letter. Cost: $25–30. Processing: 3–5 business days. The medical e-visa is valid for 1 year with multiple entries — relevant for patients who need radiation over 6–7 weeks with a short return home mid-treatment.
Companion travel: For major surgery like robotic prostatectomy, having a companion for the first 2 weeks is highly recommended. Companions can be included on the medical visa application. Companion accommodation near major hospitals is available for $40–80/night.
Language: English is the language of medical education in India. Your oncologist, surgeon, and all clinical staff at major private hospitals communicate in English without interpreters.
Currency: The Indian Rupee (INR). Major hospitals accept USD, GBP, EUR, and card payments. ATMs near hospitals are plentiful.
For a complete step-by-step planning guide, visit our first-time medical travel to India guide.
How Arodya Helps Prostate Cancer Patients
Arodya specialises in coordinating oncology treatment trips for patients from Africa:
- Free remote second opinion: Send your biopsy, PSA history, and MRI through our intake form. We arrange specialist review within 48–72 hours.
- Treatment comparison: We can obtain robotic surgery quotes from Apollo, Fortis, Medanta, and Max simultaneously so you can compare specialists and prices.
- Full coordination: Once you decide, Arodya confirms the hospital appointment letter for your visa, coordinates pre-operative investigations, and assigns a dedicated case coordinator who is reachable by WhatsApp throughout your trip.
- Medication procurement: For patients who need long-term hormonal therapy, Arodya can help you access Indian-manufactured enzalutamide and abiraterone at a fraction of their cost in Nigeria or South Africa.
Prostate cancer is treatable, particularly when caught at localised or locally advanced stages — and the treatment available in India matches the best available anywhere in the world at a price accessible to patients who cannot afford Western healthcare. If you or a family member has received a prostate cancer diagnosis and are exploring your options, the next step is a remote second opinion from an Indian specialist. It costs nothing, takes a few days, and gives you a clear treatment recommendation from a high-volume expert before you make any further decisions.
